More than two decades of research in multiple mouse models of RP with different underlying mutations (rd1, Rho−/−, RhoP23H, rd16, and rd7) has established that NR2E3 can rescue retinal degeneration and RP disease progression (19, 26, 35, 36). This evidence concerns the gene RHO and retinitis pigmentosa 1.